Hopp til innhold
Close

Get alerts of updates about «Evaluering av sikkerhet og effekt for Ebola vaksine i et distrikt i Guinea»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • Evaluering av sikkerhet og effekt for Ebola vaksine i et distrikt i Guinea

Oops, something went wrong...

... contact nettredaksjon@fhi.no.

... reload the page and try again-

Project

Evaluering av sikkerhet og effekt for Ebola vaksine i et distrikt i Guinea - project description

Published Updated

The study aims to evaluate Ebola vaccine efficacy and the use of ring vaccination as a vaccine delivery strategy in a population in West Africa.


Summary

The current outbreak of Ebola Virus Disease (EVD) in West Africa is by far the largest outbreak ever recorded. The WHO meeting in sept-14 has proposed to fast-track clinical Ebola vaccine trials. This study has the potential to contribute to control the Ebola epidemic in West Africa and possibly prevent new, future outbreaks. The study aims to evaluate Ebola vaccine efficacy and the use of ring vaccination as a vaccine delivery strategy in a population in West Africa. In addition, it will offer vaccination to frontline workers. The study will also give more information on safety and immunogenicity of the vaccine, and possibly contribute to the establishment of a correlate of protection. The planned research will strengthen the capacity of conducting high quality research in Guinea through an international collaboration and engagement of the local community and authorities of Guinea. Furthermore, the study may help to design implementation strategy of Ebola vaccines in West Africa.

See the full project description at Cristin for more information about results, researchers, contact information etc.

Project participants

Project leader

John-Arne Røttingen, Norwegian Institute of Public Health

Project participants

Gunnstein Norheim, Norwegian Institute of Public Health

Start

15.12.2014

End

30.06.2017

Status

Concluded

Approvals

Regional committees for medical and health research ethics

Project owner/ Project manager

Norwegian Institute of Public Health

Participant at FHI

Gunnstein Norheim